The Egg Factor

In this episode of The Egg Factor, Dr. Norbert Gleicher is joined by Professor Raoul Orvieto to discuss one of the most debated topics in reproductive medicine: whether preimplantation genetic testing for aneuploidy (PGT-A) improves IVF outcomes or may have unintended limitations. 

They explore the science behind embryo testing, its impact on embryo selection and transfer decisions, and the challenges of interpreting genetic results. Tune in for an in-depth discussion of the evidence, controversies, and clinical considerations shaping the role of PGT-A in modern IVF.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: https://centerforhumanreprod.com

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this episode of The Egg Factor, Dr. Norbert Gleicher takes a closer look at PGT-A and the questions patients should consider when evaluating genetic testing during IVF treatment.

He discusses what PGT-A can tell us, where its limitations lie, and why a broader understanding of the science is important when making decisions about fertility treatment. Listen to the episode now to learn more about PGT-A and what patients should know.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: https://centerforhumanreprod.com

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this episode of The Egg Factor, Dr. Norbert Gleicher discusses miscarriage risk after 40 and the biological factors that can contribute to pregnancy loss.

Dr. Gleicher explains how egg quality, chromosomal abnormalities, ovarian aging, and other factors may influence miscarriage risk as women age. He also discusses what women over 40 should understand when trying to conceive and how individualized fertility care may help guide treatment decisions.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: https://centerforhumanreprod.com

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this episode of The Egg Factor, Dr. David Barad takes a closer look at PGT-A and the questions patients often have about its role in IVF.

He discusses what PGT-A can and cannot tell us, how the testing is used, and why understanding its limitations is important when considering fertility treatment options. Listen to this episode now to learn more about the science behind PGT-A and what patients should know before making decisions about genetic testing.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: https://centerforhumanreprod.com

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this episode of The Egg Factor, Dr. Norbert Gleicher and Dr. Sonia Gayete-Lafuente discuss the role of supplements in reproductive health and fertility treatment. They explore which nutrients may be beneficial, how supplements may support egg and sperm health, and why individualized recommendations are important.

Dr. Gleicher and Dr. Gayete-Lafuente also discuss common misconceptions about fertility supplements and what patients should consider when deciding whether to add supplements to their fertility journey.

Tune in to learn more about the science behind supplements and fertility and how nutrition and supplementation may fit into a personalized approach to reproductive care.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: https://centerforhumanreprod.com

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

How much can AMH really tell you about your fertility? In this episode of The Egg Factor, Dr. David Barad and Dr. Sonia Gayete-Lafuente take a closer look at what AMH testing can and cannot tell us.

They explore what AMH testing can tell us about fertility, how it is used in reproductive medicine, and the limitations of relying on AMH alone when evaluating fertility.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: https://centerforhumanreprod.com

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this episode of The Egg Factor, Dr. Norbert Gleicher explores when repeating IVF cycles may improve a patient’s chances of success and when continuing treatment may no longer make sense. He discusses the factors patients should consider when deciding whether to pursue another cycle and why individualized treatment planning is essential.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: https://centerforhumanreprod.com

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this episode of The Egg Factor, Dr. Norbert Gleicher explores whether fresh or frozen embryo transfers may lead to different outcomes for women over 40. He discusses the science behind each approach and why individualized treatment decisions are especially important as reproductive age increases.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: https://centerforhumanreprod.com

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

Endometriosis is one of the most common causes of infertility, but does a diagnosis automatically mean IVF is the next step? In this episode of The Egg Factor, Dr. Sonia Gayete-Lafuente explores the relationship between endometriosis and fertility, explaining why every patient's journey is different.

Tune in as she discusses how endometriosis can affect reproductive health, when IVF may be recommended, and what other treatment options may be available depending on a woman's age, symptoms, ovarian reserve, and fertility goals.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: https://centerforhumanreprod.com/

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork

In this episode of The Egg Factor, Dr. Norbert Gleicher is joined by Dr. Pasquale Patrizio and Dr. David Albertini for a thought-provoking conversation about the rapidly evolving field of reproductive medicine.

Together, they explore the growing role of artificial intelligence, genetics, advanced reproductive technologies, and emerging scientific approaches and how these developments could influence the way infertility is understood, diagnosed, and treated in the years ahead. This episode takes a closer look at where reproductive medicine may be headed and what these innovations could mean for patients.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. 

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: https://centerforhumanreprod.com

Facebook: https://www.facebook.com/chrnewyork 

Instagram: https://www.instagram.com/chrnewyork/ 

Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ 

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ 

TikTok: https://www.tiktok.com/@chrnewyork